SpineGuard Collaborates With the European Project FAROS (Functional Accurate RObotic Surgery)
02 Februar 2021 - 6:00PM
Business Wire
Make orthopedic surgical robots smarter and
less dependent on x-rays
Regulatory News:
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative
company that deploys its DSG® (Dynamic Surgical Guidance) sensing
technology to secure and streamline the placement of bone implants,
announced today its collaboration on the European project FAROS
(Functional Accurate RObotic Surgery).
The FAROS project started on January 1st, 2021 with a three-year
term, it is financed by Horizon 2020, the largest European Union
research and innovation program, deploying close to 80 billion
euros financing over a seven-year period. Four prestigious
universities are participants to this project: KU Leuven, Sorbonne
Université, King's College London and Universität Zürich.
SpineGuard is a project collaborator, along with the Balgrist
University Hospital of Zurich.
As supporting organization, SpineGuard will provide the FAROS
members their DSG technology. This key feedback technology will
help the surgical robot which will possess multiple sensing
capabilities to execute complex surgical tasks in an autonomous and
controlled manner. DSG is expected to be pivotal in ensuring this
happens in a safe and precise fashion. Moreover, two SpineGuard
members have a seat on the External Advisory Board of the project:
Maurice Bourlion, Board director and scientific advisor, and
Thibault Chandanson, R&D director. Jimmy Da Silva, PhD student
and engineer at SpineGuard in the context of a CIFRE contract with
Sorbonne University's ISIR (Institute for Intelligent Systems and
Robotics) is also part of the research team.
Stéphane Bette, cofounder and deputy CEO of SpineGuard,
declares: "We are thrilled and proud of being selected by the
four prestigious universities of the FAROS project to contribute to
their effort by providing our DSG sensing technology, unique
know-how in the field of real-time surgical guidance without x-ray
imaging. This project, which entails the development of an
artificial intelligence, is in straight alignment with the work
accomplished for three years with Guillaume Morel's ISIR at
Sorbonne University. We expect multiple positive downfalls for
SpineGuard: scientific and technologic mastery, innovations,
commercial applications, visibility, and enhancement of our
strategic value. It is for all these reasons that we are fully
committed to support this project which is perfectly in line with
our innovation strategy to secure and streamline the placement of
implants in the skeleton."
Guillaume Morel, Professor at Sorbonne University, adds:
"The idea behind FAROS is largely inspired by our first
collaborative research with SpineGuard. It consists in breaking the
paradigm of guidance based exclusively on image, which dominates
today's surgical and orthopedic robotics and whose limits are
well-known: deformations causing errors, loss of anatomical
information in images, radiation dangers, etc. How can we solve
these issues? By integrating several non-visual sensors as surgeons
do when they guide their gesture, in particular within the last
millimeters. That is precisely where the DSG technology is
attractive, as it has been proven in the operating room. Our idea
is to use it in combination with other sensors such as
ultrasound-based sensors, which are by the way also developed by
SpineGuard. From the multiple information, we will create
artificial intelligence algorithms that will provide a functional
indication (nature and state of tissues, progress of gesture) as
opposed to solely geometrical. On the robotic standpoint, such an
approach is truly disruptive and could eventually lead to surgical
gestures performed by robots in full autonomy. A revolution."
About SpineGuard® Founded in 2009 in France and the USA
by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative
company deploying its proprietary radiation-free real time sensing
technology DSG® (Dynamic Surgical Guidance) to secure and
streamline the placement of implants in the skeleton. SpineGuard
designs, develops and markets medical devices that have been used
in over 80,000 surgical procedures worldwide. Sixteen studies
published in peer-reviewed scientific journals have demonstrated
the multiple benefits DSG® offers to patients, surgeons, surgical
staff and hospitals. Building on these solid fundamentals and
several strategic partnerships, SpineGuard has expanded its
technology platform in a disruptive innovation: the « smart »
pedicle screw launched late 2017 and is broadening the scope of
applications in dental implantology and surgical robotics. DSG® was
co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D.,
and Alain Vanquaethem, Biomedical Engineer.
For further information, visit www.spineguard.com
Disclaimer The SpineGuard securities may not be offered
or sold in the United States as they have not been and will not be
registered under the Securities Act or any United States state
securities laws, and SpineGuard does not intend to make a public
offer of its securities in the United States. This is an
announcement and not a prospectus, and the information contained
herein does and shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the
securities referred to herein in the United States in which such
offer, solicitation or sale would be unlawful prior to registration
or exemption from registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210202005814/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel.: +33 1
45 18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi CFO Tél.: +33 1 45 18 45 19
m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Louis Tilquin Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Spineguard (EU:ALSGD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024